AU2002354460A1 - Medicinal composition - Google Patents

Medicinal composition

Info

Publication number: AU2002354460A1
Authority: AU; Australia
Prior art keywords: medicinal composition; medicinal; composition
Prior art date: 2001-12-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002354460A

Inventor

Shinichi Kurakata

Tomoyuki Shibata

Naomi Shimazaki

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sankyo Co Ltd

Original Assignee

Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-11

Filing date

2002-12-10

Publication date

2003-07-09

2002-12-10 Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd

2003-07-09 Publication of AU2002354460A1 publication Critical patent/AU2002354460A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002354460A 2001-12-11 2002-12-10 Medicinal composition Abandoned AU2002354460A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001-376954		2001-12-11
JP2001376954		2001-12-11
PCT/JP2002/012939 WO2003053440A1 (en)	2001-12-11	2002-12-10	Medicinal composition

Publications (1)

Publication Number	Publication Date
AU2002354460A1 true AU2002354460A1 (en)	2003-07-09

Family

ID=19185039

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002354460A Abandoned AU2002354460A1 (en)	2001-12-11	2002-12-10	Medicinal composition

Country Status (3)

Country	Link
AU (1)	AU2002354460A1 (en)
TW (1)	TW200300677A (en)
WO (1)	WO2003053440A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7816552B2 (en)	2004-09-28	2010-10-19	Sankyo Company, Limited	Intermediate of 6-substituted 1-methyl-1-H-benzimidazole derivative and method for producing same
BRPI0707671A2 (en) *	2006-02-09	2011-05-10	Daiichi Sankyo Co Ltd	anti-cancer pharmaceutical composition
TW200838512A (en) *	2007-02-08	2008-10-01	Daiichi Sankyo Co Ltd	Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof
JPWO2010013768A1 (en)	2008-07-31	2012-01-12	第一三共株式会社	Crystal of thiazolidinedione compound and method for producing the same
WO2010013769A1 (en)	2008-07-31	2010-02-04	第一三共株式会社	Crystal of thiazolidinedione compound, and process for production thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994015901A1 (en) *	1993-01-11	1994-07-21	Ligand Pharmaceuticals Inc.	Compounds having selectivity for retinoid x receptors
GB9604242D0 (en) *	1996-02-28	1996-05-01	Glaxo Wellcome Inc	Chemical compounds
CA2274756C (en) *	1996-12-11	2007-03-13	Bruce M. Spiegelman	Methods and pharmaceutical compositions for inhibiting tumour cell growth
US6646008B1 (en) *	1996-12-31	2003-11-11	The Salk Institute For Biological Studies	Treatment of disease states which result from neoplastic cell proliferation using PPAR-γ activators and compositions useful therefor
DE69824194T2 (en) *	1997-10-08	2005-01-13	Sankyo Co., Ltd.	SUBSTITUTED CONDENSED HETEROCYCLIC COMPOUNDS
AU1740900A (en) *	1998-11-20	2000-06-13	Genentech Inc.	Method of inhibiting angiogenesis
AU2001278738A1 (en) *	2000-08-16	2002-02-25	Sankyo Company Limited	Medicinal compositions for preventing and treating cancer

2002
- 2002-12-10 TW TW091135697A patent/TW200300677A/en unknown
- 2002-12-10 WO PCT/JP2002/012939 patent/WO2003053440A1/en not_active Ceased
- 2002-12-10 AU AU2002354460A patent/AU2002354460A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TW200300677A (en)	2003-06-16
WO2003053440A1 (en)	2003-07-03

Publication	Publication Date	Title
AU2002313236A1 (en)	2003-05-15	Medicinal compositions
AU2002302147A1 (en)	2003-06-12	Pharmaceutical composition
AU2002258221A1 (en)	2003-05-08	Medicinal composition
AU2002253039A1 (en)	2003-02-27	Tramadol-based medicament
EP1398040A4 (en)	2011-03-02	Medicinal composition
AU2002214324A1 (en)	2002-08-08	Medicinal compositions
AU2001290239A1 (en)	2002-04-02	Medicinal composition
AU2002241114A1 (en)	2002-10-08	Composition
AU2002365093A1 (en)	2003-07-09	Therapeutic compositions
AUPR600601A0 (en)	2001-07-26	Therapeutic compositions
AU4085201A (en)	2001-09-24	Pharmaceutical composition
AU2003284460A1 (en)	2004-06-23	Medicinal composition
AU2002354460A1 (en)	2003-07-09	Medicinal composition
AU2003280799A1 (en)	2004-06-15	Medicinal composition
AU3586401A (en)	2001-09-17	Pharmaceutical composition
GB0114746D0 (en)	2001-08-08	Medicinal composition
AU2001278705A1 (en)	2002-02-25	Pharmaceutical composition
AU2001282541A1 (en)	2002-06-13	Medicinal compositions
AU2003280678A1 (en)	2004-05-25	Medicinal composition
AUPR529701A0 (en)	2001-06-21	Pharmaceutical composition
AU2002346223A1 (en)	2003-05-15	Medicinal compositions
AU2002361450A1 (en)	2003-07-09	Novel pharmaceutical
AU2002226759A1 (en)	2002-08-12	Medicinal composition
AU2002100921A4 (en)	2003-06-05	Pharmaceutical composition
AU2002335161A1 (en)	2004-04-30	Medicinal composition

Legal Events

Date	Code	Title	Description
2004-08-26	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase